Stevanato Group to Present at Upcoming Investor Conference
07 Enero 2025 - 3:30PM
Business Wire
Stevanato Group S.p.A. (NYSE: STVN), a leading global provider
of drug containment and delivery solutions to the pharmaceutical,
biotechnology, and life sciences industries, announced today that
it will participate in the CJS Securities 25th Annual “New Ideas
for the New Year” Investor Conference on Tuesday, January 14, 2025,
at 8:00 a.m. ET.
A live event webcast will be available on the Company’s website
at www.stevanatogroup.com under the "Investors" section. A replay
of the webcast will be available for approximately 90 days after
the event.
About Stevanato Group
Founded in 1949, Stevanato Group is a leading global provider of
drug containment, drug delivery, and diagnostic solutions to the
pharmaceutical, biotechnology, and life sciences industries. The
Group delivers an integrated, end-to-end portfolio of products,
processes, and services that address customer needs across the
entire drug life cycle at each of the development, clinical, and
commercial stages. Stevanato Group’s core capabilities in
scientific research and development, its commitment to technical
innovation, and its engineering excellence are central to its
ability to offer value-added solutions to clients. To learn more,
visit: www.stevanatogroup.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20250107770594/en/
Media Stevanato Group media@stevanatogroup.com
Investor Relations Lisa Miles
lisa.miles@stevanatogroup.com
Stevanato (NYSE:STVN)
Gráfica de Acción Histórica
De Dic 2024 a Ene 2025
Stevanato (NYSE:STVN)
Gráfica de Acción Histórica
De Ene 2024 a Ene 2025
